Quantcast

Latest AstraZeneca Stories

2014-07-08 12:28:38

MERIDEN, Conn., July 8, 2014 /PRNewswire/ -- Protein Sciences Corporation announced today that the FDA has approved the Company's strain change amendment for its seasonal influenza vaccine, Flublok. Every year influenza vaccine manufacturers must receive approval from the Agency for changes they make to the upcoming season's manufacturing process and product formulation, as the influenza vaccine is adapted annually. Early approval for Flublok will enable delivery on time to...

2014-07-02 08:24:16

LONDON, July 2, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: AstraZeneca PLC - Product Pipeline Review - 2014 http://www.reportbuyer.com/computing_electronics/manufacturing/astrazeneca_plc_product_pipeline_review_2013.html AstraZeneca PLC - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'AstraZeneca PLC - Product Pipeline Review - 2014', provides an overview of the AstraZeneca PLC's pharmaceutical research and development focus....

2014-06-24 12:28:56

LONDON and BOSTON, June 24, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, announces that its President, Dan Grau, will present a company overview at the JMP Securities Healthcare Conference (24-25 June 2014, New York, NY, USA). His presentation will take place on 25 June at 9.30 am EDT. For a full list of events at which Heptares will be present, please visit http://www.heptares.com About...

2014-06-19 16:26:04

SAN FRANCISCO, June 19, 2014 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) reported that partner AstraZeneca today announced that the New England Journal of Medicine (NEJM) has published results of two pivotal Phase III studies - KODIAC-4 and KODIAC-5 of naloxegol, an investigational treatment for opioid-induced constipation (OIC). Opioids play an important role in chronic pain relief by binding to mu-receptors in the brain, but they also bind to mu-receptors in the bowel. That is why...

2014-06-19 16:25:52

LONDON, June 19, 2014 /PRNewswire/ -- AstraZeneca today announced that the New England Journal of Medicine (NEJM) has published results of two pivotal Phase III studies - KODIAC-4 and KODIAC-5 of naloxegol, an investigational treatment for opioid-induced constipation (OIC). Opioids play an important role in chronic pain relief by binding to mu-receptors in the brain, but they also bind to mu-receptors in the bowel. That is why patients taking opioids for chronic pain can develop OIC. In...

2014-06-19 08:28:10

Carbapenem Resistance Consortium Includes AstraZeneca, Cepheid, Cubist, and GSK SUNNYVALE, Calif., June 19, 2014 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced a new collaboration with AstraZeneca, Cubist Pharmaceuticals, Inc., and GSK intended to promote transformational change in infectious disease therapy by developing a rapid diagnostic test that can target multi-drug resistant pathogens and support the appropriate use of antibiotics. Targeting bacterial infections with the right...

2014-06-18 16:26:18

RESEARCH TRIANGLE PARK, N.C., June 18, 2014 /PRNewswire-USNewswire/ -- The United Nations projects that by 2050, we'll have nine billion people in the world. Those additional 1.8 billion people will need to eat. Where will all that food come from? It's a question that North Carolina companies are researching in earnest. For example, we know we'll need crops that tolerate drought, but will there be new ways of controlling pests and disease? North Carolina has companies working on that. We'll...

2014-06-17 12:29:08

Selected academic researchers to receive access to AstraZeneca's compound library to aid in the discovery of new medicines BALTIMORE, June 17, 2014 /PRNewswire-USNewswire/ -- The Academic Drug Discovery Consortium (ADDC) announced today a collaboration between ADDC and AstraZeneca aimed at facilitating efforts by researchers from academia and institutions towards the discovery of novel compounds with potential pharmaceutical application. More specifically, the goal of this...

2014-06-17 12:28:42

MERIDEN, Conn., June 17, 2014 /PRNewswire/ -- Protein Sciences Corporation announced today that BARDA, within the U.S. Department of Health and Human Services, exercised Option Period 2 of its contract with the Company (contract number HHS0100200900106C) to support development, scale-up and expanded licensure of the Company's influenza vaccines, Flublok® (seasonal) and Panblok® (pandemic). Option Period 2 has a budget of $50.6 million and will run through December 31, 2015. The...

2014-06-17 12:22:45

CARY, N.C., June 17, 2014 /PRNewswire/ -- Summit Agro USA (SAUS) announces the appointment of William (Bill) M. Lewis to the position of President and CEO. Mr. Lewis is replacing Bill Wisdom, who retired at the end of March. Mr. Lewis has extensive agricultural chemical industry experience having held numerous management positions with ICI, Zeneca, Syngenta and Arysta over the past 28 years. In the past two years, Mr. Lewis has owned and operated two John Deere dealerships in the...


Word of the Day
virgule
  • A punctuation mark (/) used to separate related items of information.
  • A little rod; a twig.
This word comes from the Late Latin 'virgula,' accentual mark, a diminutive of 'virga,' rod.
Related